Image description

English Info


Occupation or position held: Chair of Urology Unit

Main activities and responsibilities Medical and Surgical treatment of Germ-Cell tumors (including novel drugs and experimental therapies) and other genitourinary malignancies. 

Integration with surgery and high-dose therapies-transplantation in multimodal treatments for genitourinary neoplasms. 
Dr. Salvioni was born in Milan on 11/05/1952. He got a degree in Medicine in 1978 with honors from the University of Milan with a thesis entitled: "Malignant tumors of the liver: our series." From 1977 he attended the Division of Surgical Oncology of the Institute for the Study and Treatment of Cancer in Milan. He specialized in 1982 with honors in Oncology at the University of Genoa, with a thesis on "Classification and Treatment of kidney cancer (particularly in relation to hormone receptors)". 

Since 1984, deals with the status of research associate, of urological cancers and in particular those of the testis, at the Division of Urologic Oncology Institute for the Study and Treatment of Cancer in Milan. 

In 1988, he specialized with honors in General Surgery at the University of Milan with the thesis: "The treatment of cancer of the penis." 

He specialized in 1999 with honors in Urology at the University of Milan, with a thesis on "The conservative treatment of penile cancers". 

From 1990 to December 2006, he has been the Medical Director of the First Level Division of Urology at the National Institute for the Study and Treatment of Cancer in Milan. 

Since January 2007, he has been Chair of Urologic Unit, IRCCS National Institute for the Study and Treatment of Cancer in Milan. He is author or coauthor of over 100 scientific publications in the field of uro-oncology. He has collaborated so far in national and international cooperative studies on testicular cancer. 

Since September 2005, he has been working as an international consultant with the Institut National du Cancer, Paris (INCA) for testicular cancer. 


He has performed as the first operator of more than 3000 surgical operations in highly specialized field of uro-oncology.